首页 > 最新文献

Canadian Medical Association journal最新文献

英文 中文
Powassan virus encephalitis in a 9-year-old. 一名 9 岁儿童感染了波瓦桑病毒性脑炎。
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-25 DOI: 10.1503/cmaj.240227
Zachary Blatman, Anne Rowan-Legg, Joshua K Schaffzin, Nagwa Wilson, Nicole Bechard
{"title":"Powassan virus encephalitis in a 9-year-old.","authors":"Zachary Blatman, Anne Rowan-Legg, Joshua K Schaffzin, Nagwa Wilson, Nicole Bechard","doi":"10.1503/cmaj.240227","DOIUrl":"10.1503/cmaj.240227","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11349341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Listeriosis in pregnancy. 妊娠期李斯特菌病
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-25 DOI: 10.1503/cmaj.241056
Jeffrey Man Hay Wong, Chelsea Elwood, Deborah Money, Julie van Schalkwyk
{"title":"Listeriosis in pregnancy.","authors":"Jeffrey Man Hay Wong, Chelsea Elwood, Deborah Money, Julie van Schalkwyk","doi":"10.1503/cmaj.241056","DOIUrl":"10.1503/cmaj.241056","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11349340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Présence de vésicules hémorragiques intraorales comme premier symptôme d’une amylose à chaîne légère d’immunoglobulines. 口腔内出血性水泡是免疫球蛋白轻链淀粉样变性病的首发症状。
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-25 DOI: 10.1503/cmaj.240119-f
Raquel María Dominguez-Lopez, Jorge Naharro-Rodriguez
{"title":"Présence de vésicules hémorragiques intraorales comme premier symptôme d’une amylose à chaîne légère d’immunoglobulines.","authors":"Raquel María Dominguez-Lopez, Jorge Naharro-Rodriguez","doi":"10.1503/cmaj.240119-f","DOIUrl":"10.1503/cmaj.240119-f","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11349343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Déprescription de la médication contre le diabète chez les personnes âgées fragiles. 对体弱老人过度开具糖尿病药物处方。
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-11 DOI: 10.1503/cmaj.231411-f
Iliana C Lega, Wade Thompson, Lisa M McCarthy
{"title":"Déprescription de la médication contre le diabète chez les personnes âgées fragiles.","authors":"Iliana C Lega, Wade Thompson, Lisa M McCarthy","doi":"10.1503/cmaj.231411-f","DOIUrl":"10.1503/cmaj.231411-f","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La fumée des incendies de forêt. 森林大火产生的烟雾
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-11 DOI: 10.1503/cmaj.240135-f
Elaheh Ghodsi, Mehdi Aloosh
{"title":"La fumée des incendies de forêt.","authors":"Elaheh Ghodsi, Mehdi Aloosh","doi":"10.1503/cmaj.240135-f","DOIUrl":"10.1503/cmaj.240135-f","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
August 2024 obituaries. 2024 年 8 月的讣告
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-11 DOI: 10.1503/cmaj.241066
{"title":"August 2024 obituaries.","authors":"","doi":"10.1503/cmaj.241066","DOIUrl":"https://doi.org/10.1503/cmaj.241066","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Afin d’éliminer le cancer du col de l’utérus au Canada, le dépistage du virus du papillome humain doit être financé à l’échelle nationale. 为了在加拿大消除宫颈癌,必须在全国范围内资助人类乳头瘤病毒筛查。
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-11 DOI: 10.1503/cmaj.240722-f
Shannon Charlebois, Sarah Kean
{"title":"Afin d’éliminer le cancer du col de l’utérus au Canada, le dépistage du virus du papillome humain doit être financé à l’échelle nationale.","authors":"Shannon Charlebois, Sarah Kean","doi":"10.1503/cmaj.240722-f","DOIUrl":"10.1503/cmaj.240722-f","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bulging fontanelle in a febrile 9-month-old girl. 一名发热的 9 个月大女孩囟门突出。
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-11 DOI: 10.1503/cmaj.240129
Takashi Shoji, Kazuki Iio, Hiroshi Sakakibara
{"title":"Bulging fontanelle in a febrile 9-month-old girl.","authors":"Takashi Shoji, Kazuki Iio, Hiroshi Sakakibara","doi":"10.1503/cmaj.240129","DOIUrl":"10.1503/cmaj.240129","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polyglobulie essentielle et hypertension portale non cirrhotique diagnostiquées en cours de grossesse. 妊娠期确诊的原发性多球蛋白血症和非肝硬化性门静脉高压症。
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-11 DOI: 10.1503/cmaj.231170-f
Cairina Frank, Noor Amily, Erin Kelly, Miriam Kimpton, Pierre Villeneuve, Paloma O'Meara
{"title":"Polyglobulie essentielle et hypertension portale non cirrhotique diagnostiquées en cours de grossesse.","authors":"Cairina Frank, Noor Amily, Erin Kelly, Miriam Kimpton, Pierre Villeneuve, Paloma O'Meara","doi":"10.1503/cmaj.231170-f","DOIUrl":"10.1503/cmaj.231170-f","url":null,"abstract":"","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renin-angiotensin system inhibitors and risk of hepatocellular carcinoma among patients with hepatitis B virus infection. 肾素-血管紧张素系统抑制剂与乙型肝炎病毒感染者罹患肝细胞癌的风险。
IF 9.4 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-11 DOI: 10.1503/cmaj.240003
Ruixuan Chen, Shiyu Zhou, Jiao Liu, Lu Li, Licong Su, Yanqin Li, Chuyao Fang, Xiaodong Zhang, Fan Luo, Qi Gao, Yuxin Lin, Zhixin Guo, Lisha Cao, Xin Xu, Sheng Nie

Background: Hepatitis B virus (HBV) infection is a common cause of liver-related morbidity and mortality. Evidence suggests that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) decrease liver fibrosis, an intermediate step between liver injury and hepatocellular carcinoma (HCC). Our aim was to investigate the association between the use of ACEIs and ARBs on incident HCC and liver-related mortality among patients with HBV infection.

Methods: We conducted a population-based study on a new-user cohort of patients seen at 24 hospitals across China. We included adult patients with HBV infection who started ACEIs or ARBs (ACEIs/ARBs), or calcium channel blockers or thiazide diuretics (CCBs/THZs) from January 2012 to December 2022. The primary outcome was incident HCC; secondary outcomes were liver-related mortality and new-onset cirrhosis. We used propensity score matching and Cox proportional hazards regression to estimate the hazard ratio (HR) and 95% confidence intervals (CIs) of study outcomes.

Results: Among 32 692 eligible patients (median age 58 [interquartile range (IQR) 48-68] yr, and 18 804 male [57.5%]), we matched 9946 pairs of patients starting ACEIs/ARBs or CCBs/THZs. During a mean follow-up of 2.3 years, the incidence rate of HCC per 1000 person-years was 4.11 and 5.94 among patients who started ACEIs/ARBs and CCBs/THZs, respectively, in the matched cohort. Use of ACEIs/ARBs was associated with lower risks of incident HCC (HR 0.66, 95% CI 0.50-0.86), liver-related mortality (HR 0.77, 95% CI 0.64-0.93), and new-onset cirrhosis (HR 0.81, 95% CI 0.70-0.94).

Interpretation: In this cohort of patients with HBV infection, new users of ACEIs/ARBs had a lower risk of incident HCC, liver-related mortality, and new-onset cirrhosis than new users of CCBs/THZs.

背景:乙型肝炎病毒(HBV)感染是肝脏相关疾病发病率和死亡率的常见原因。有证据表明,血管紧张素转换酶抑制剂(ACEI)和血管紧张素 II 受体阻滞剂(ARB)可减少肝纤维化,而肝纤维化是肝损伤和肝细胞癌(HCC)之间的中间环节。我们的目的是研究 ACEIs 和 ARBs 的使用与 HBV 感染者中 HCC 发生率和肝脏相关死亡率之间的关系:我们对在中国 24 家医院就诊的新使用者队列进行了一项基于人群的研究。我们纳入了从 2012 年 1 月至 2022 年 12 月开始服用 ACEIs 或 ARBs(ACEIs/ARBs)或钙通道阻滞剂或噻嗪类利尿剂(CCBs/THZs)的成年 HBV 感染患者。主要结局是发生 HCC;次要结局是肝脏相关死亡率和新发肝硬化。我们采用倾向评分匹配和 Cox 比例危险度回归来估计研究结果的危险度比 (HR) 和 95% 置信区间 (CI):在 32 692 名符合条件的患者(中位年龄 58 [四分位距 (IQR) 48-68] 岁,18 804 名男性 [57.5%])中,我们匹配了 9946 对开始使用 ACEIs/ARBs 或 CCBs/THZs 的患者。在平均 2.3 年的随访期间,配对队列中开始使用 ACEIs/ARBs 和 CCBs/THZs 的患者的 HCC 发病率分别为每千人年 4.11 例和 5.94 例。使用 ACEIs/ARBs 可降低发生 HCC(HR 0.66,95% CI 0.50-0.86)、肝脏相关死亡率(HR 0.77,95% CI 0.64-0.93)和新发肝硬化(HR 0.81,95% CI 0.70-0.94)的风险:在这组HBV感染患者中,ACEIs/ARBs新用户发生HCC、肝脏相关死亡率和新发肝硬化的风险低于CCBs/THZs新用户。
{"title":"Renin-angiotensin system inhibitors and risk of hepatocellular carcinoma among patients with hepatitis B virus infection.","authors":"Ruixuan Chen, Shiyu Zhou, Jiao Liu, Lu Li, Licong Su, Yanqin Li, Chuyao Fang, Xiaodong Zhang, Fan Luo, Qi Gao, Yuxin Lin, Zhixin Guo, Lisha Cao, Xin Xu, Sheng Nie","doi":"10.1503/cmaj.240003","DOIUrl":"10.1503/cmaj.240003","url":null,"abstract":"<p><strong>Background: </strong>Hepatitis B virus (HBV) infection is a common cause of liver-related morbidity and mortality. Evidence suggests that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) decrease liver fibrosis, an intermediate step between liver injury and hepatocellular carcinoma (HCC). Our aim was to investigate the association between the use of ACEIs and ARBs on incident HCC and liver-related mortality among patients with HBV infection.</p><p><strong>Methods: </strong>We conducted a population-based study on a new-user cohort of patients seen at 24 hospitals across China. We included adult patients with HBV infection who started ACEIs or ARBs (ACEIs/ARBs), or calcium channel blockers or thiazide diuretics (CCBs/THZs) from January 2012 to December 2022. The primary outcome was incident HCC; secondary outcomes were liver-related mortality and new-onset cirrhosis. We used propensity score matching and Cox proportional hazards regression to estimate the hazard ratio (HR) and 95% confidence intervals (CIs) of study outcomes.</p><p><strong>Results: </strong>Among 32 692 eligible patients (median age 58 [interquartile range (IQR) 48-68] yr, and 18 804 male [57.5%]), we matched 9946 pairs of patients starting ACEIs/ARBs or CCBs/THZs. During a mean follow-up of 2.3 years, the incidence rate of HCC per 1000 person-years was 4.11 and 5.94 among patients who started ACEIs/ARBs and CCBs/THZs, respectively, in the matched cohort. Use of ACEIs/ARBs was associated with lower risks of incident HCC (HR 0.66, 95% CI 0.50-0.86), liver-related mortality (HR 0.77, 95% CI 0.64-0.93), and new-onset cirrhosis (HR 0.81, 95% CI 0.70-0.94).</p><p><strong>Interpretation: </strong>In this cohort of patients with HBV infection, new users of ACEIs/ARBs had a lower risk of incident HCC, liver-related mortality, and new-onset cirrhosis than new users of CCBs/THZs.</p>","PeriodicalId":9609,"journal":{"name":"Canadian Medical Association journal","volume":null,"pages":null},"PeriodicalIF":9.4,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Canadian Medical Association journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1